BUSINESS● LOWJun 25 · Jun 25, 2026, 9:48 AM
ARS Pharmaceuticals plunges 23% as neffy fails to secure insurance coverage
Seeking Alpha Tech
ARS Pharmaceuticals experienced a 23% stock drop due to its product, neffy, failing to secure insurance coverage. This development has a notable impact on the company's market performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS36m agoMiddle East physical oil prices are falling while Brent crude soars to six-month highsSeeking Alpha TechBUSINESS37m agoOpinion: China’s model is cracking and Mexico (and the world) should get ready nowMexico News Daily